Karanasos A, Aznaouridis K, Latsios G, et al. Impact of smoking status on disease severity and mortality of hospitalized patients with COVID-19 infection: a systematic review and meta-analysis. Nicotine Tob Res 2020: ntaa107. DOI: 10.1093/ntr/ntaa107.
Russo P, Bonassi S, Giacconi R, et al. COVID-19 and smoking: is nicotine the hidden link? Eur Respir J 2020;55(6):2001116. DOI: 10.1183/13993003.01116-2020.
Cure E, Cumhur Cure M. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes Metab Syndr 2020;14(4):349–350. DOI: 10.1016/j.dsx.2020. 04.019.
Lapperre TS, Postma DS, Gosman MM, et al. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 2006;61(2):115–121. DOI: 10.1136/thx.2005.040519.
Benowitz NL, Jacob 3rd P, Kozlowski LT, et al. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med 1986;315(21):1310–1313. DOI: 10.1056/NEJM198611203152102.
Rigden HM, Alias A, Havelock T, et al. Squamous metaplasia is Increased in the bronchial epithelium of smokers with chronic obstructive Pulmonary disease. PLoS One 2016;11(5):e0156009. DOI: 10.1371/journal.pone.0156009.